CTLA4 and neoplasm: Analysis of MMRd tumors treated with a combination of anti-PD-1 and anti-CTLA-4 showed a role for γδ-T cells in targeting MMRd tumor cells with defective antigen presentation potentially via de NKG2D/NKG2DL ligand-receptor interaction (188).